Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism
Abstract Context The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phen...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2017-09, Vol.102 (9), p.3085-3090 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3090 |
---|---|
container_issue | 9 |
container_start_page | 3085 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 102 |
creator | Aycan, Zehra Cangul, Hakan Muzza, Marina Bas, Veysel N Fugazzola, Laura Chatterjee, V Krishna Persani, Luca Schoenmakers, Nadia |
description | Abstract
Context
The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined.
Case Description
We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred.
Conclusion
This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.
Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH. |
doi_str_mv | 10.1210/jc.2017-00529 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5587079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/jc.2017-00529</oup_id><sourcerecordid>1970003574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4919-a0f524f675558803d101b2e377283a9a62242f7b6d74f06d4afb7ea0760932483</originalsourceid><addsrcrecordid>eNp9kM1P3DAUxK2qVdlCj1xRpF64mD5_xfEFqVpoQaLiAio3y5s4xNtsvLUd0P73ddgFtUjtyfbzb-aNBqFDAieEEvi8rE8oEIkBBFVv0IwoLrAkSr5FMwBKsJL0bg99iHEJQDgX7D3ao1XJmAA5Q5dn7t4Ori7Obq_vSGGG5ulGi-9jMsn5IRZuKOYm2lj8cKkr5n6YBMn0xcVm7VO3Cd41Lq4O0LvW9NF-3J376Pbr-c38Al9df7ucf7nCNVdEYQOtoLwtpRCiqoA1BMiCWiYlrZhRpqSU01YuykbyFsqGm3YhrQFZgmKUV2wfnW591-NiZZvaDimYXq-DW5mw0d44_ffP4Dp97x903idBqmzwaWcQ_K_RxqSXfgxDzqxzbQDAhOSZwluqDj7GYNuXDQT01Lxe1npqXj81n_mjP2O90M9VZ4BsgUffJxviz358tEF31vSpe22Kn035fzQ5KvBSVnhSgMovPI1Ilh1vZX5c_yv2bsNvdAqoTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1970003574</pqid></control><display><type>article</type><title>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</title><source>ProQuest One Community College</source><source>MEDLINE</source><source>ProQuest Central (Alumni Edition)</source><source>Journals@Ovid Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><source>ProQuest Central</source><creator>Aycan, Zehra ; Cangul, Hakan ; Muzza, Marina ; Bas, Veysel N ; Fugazzola, Laura ; Chatterjee, V Krishna ; Persani, Luca ; Schoenmakers, Nadia</creator><creatorcontrib>Aycan, Zehra ; Cangul, Hakan ; Muzza, Marina ; Bas, Veysel N ; Fugazzola, Laura ; Chatterjee, V Krishna ; Persani, Luca ; Schoenmakers, Nadia</creatorcontrib><description>Abstract
Context
The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined.
Case Description
We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) <0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G>C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred.
Conclusion
This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.
Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2017-00529</identifier><identifier>PMID: 28633507</identifier><language>eng</language><publisher>Washington, DC: Endocrine Society</publisher><subject>Biosynthesis ; Case Reports ; Chemical reactions ; Codon, Nonsense ; Cohort Studies ; Congenital diseases ; Congenital Hypothyroidism - diagnosis ; Congenital Hypothyroidism - genetics ; Dual Oxidases ; Environmental factors ; Female ; Genetic Predisposition to Disease ; Genetic Variation ; Genotype ; Homology ; Humans ; Hydrogen peroxide ; Hypothyroidism ; Infant ; Infant, Newborn ; Iodide peroxidase ; Iodination ; Iodine ; Male ; Mutation ; NAD ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Nonsense mutation ; Pedigree ; Peroxidase ; Phenotype ; Phosphates ; Retrospective Studies ; Severity of Illness Index ; Siblings ; Splicing ; Thyroid ; Thyroid Function Tests ; Thyroid gland ; Thyroid-stimulating hormone ; Thyroxine</subject><ispartof>The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3085-3090</ispartof><rights>Copyright © Oxford University Press 2015</rights><rights>Copyright © 2017 Endocrine Society</rights><rights>Copyright © Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4919-a0f524f675558803d101b2e377283a9a62242f7b6d74f06d4afb7ea0760932483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1970003574?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,315,781,785,886,21393,21394,27929,27930,33535,33749,43664,43810,64390,64394,72474,73133,73134,73136</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28633507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aycan, Zehra</creatorcontrib><creatorcontrib>Cangul, Hakan</creatorcontrib><creatorcontrib>Muzza, Marina</creatorcontrib><creatorcontrib>Bas, Veysel N</creatorcontrib><creatorcontrib>Fugazzola, Laura</creatorcontrib><creatorcontrib>Chatterjee, V Krishna</creatorcontrib><creatorcontrib>Persani, Luca</creatorcontrib><creatorcontrib>Schoenmakers, Nadia</creatorcontrib><title>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Abstract
Context
The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined.
Case Description
We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) <0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G>C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred.
Conclusion
This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.
Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH.</description><subject>Biosynthesis</subject><subject>Case Reports</subject><subject>Chemical reactions</subject><subject>Codon, Nonsense</subject><subject>Cohort Studies</subject><subject>Congenital diseases</subject><subject>Congenital Hypothyroidism - diagnosis</subject><subject>Congenital Hypothyroidism - genetics</subject><subject>Dual Oxidases</subject><subject>Environmental factors</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Variation</subject><subject>Genotype</subject><subject>Homology</subject><subject>Humans</subject><subject>Hydrogen peroxide</subject><subject>Hypothyroidism</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Iodide peroxidase</subject><subject>Iodination</subject><subject>Iodine</subject><subject>Male</subject><subject>Mutation</subject><subject>NAD</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Nonsense mutation</subject><subject>Pedigree</subject><subject>Peroxidase</subject><subject>Phenotype</subject><subject>Phosphates</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Siblings</subject><subject>Splicing</subject><subject>Thyroid</subject><subject>Thyroid Function Tests</subject><subject>Thyroid gland</subject><subject>Thyroid-stimulating hormone</subject><subject>Thyroxine</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kM1P3DAUxK2qVdlCj1xRpF64mD5_xfEFqVpoQaLiAio3y5s4xNtsvLUd0P73ddgFtUjtyfbzb-aNBqFDAieEEvi8rE8oEIkBBFVv0IwoLrAkSr5FMwBKsJL0bg99iHEJQDgX7D3ao1XJmAA5Q5dn7t4Ori7Obq_vSGGG5ulGi-9jMsn5IRZuKOYm2lj8cKkr5n6YBMn0xcVm7VO3Cd41Lq4O0LvW9NF-3J376Pbr-c38Al9df7ucf7nCNVdEYQOtoLwtpRCiqoA1BMiCWiYlrZhRpqSU01YuykbyFsqGm3YhrQFZgmKUV2wfnW591-NiZZvaDimYXq-DW5mw0d44_ffP4Dp97x903idBqmzwaWcQ_K_RxqSXfgxDzqxzbQDAhOSZwluqDj7GYNuXDQT01Lxe1npqXj81n_mjP2O90M9VZ4BsgUffJxviz358tEF31vSpe22Kn035fzQ5KvBSVnhSgMovPI1Ilh1vZX5c_yv2bsNvdAqoTA</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Aycan, Zehra</creator><creator>Cangul, Hakan</creator><creator>Muzza, Marina</creator><creator>Bas, Veysel N</creator><creator>Fugazzola, Laura</creator><creator>Chatterjee, V Krishna</creator><creator>Persani, Luca</creator><creator>Schoenmakers, Nadia</creator><general>Endocrine Society</general><general>Copyright Oxford University Press</general><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>201709</creationdate><title>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</title><author>Aycan, Zehra ; Cangul, Hakan ; Muzza, Marina ; Bas, Veysel N ; Fugazzola, Laura ; Chatterjee, V Krishna ; Persani, Luca ; Schoenmakers, Nadia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4919-a0f524f675558803d101b2e377283a9a62242f7b6d74f06d4afb7ea0760932483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biosynthesis</topic><topic>Case Reports</topic><topic>Chemical reactions</topic><topic>Codon, Nonsense</topic><topic>Cohort Studies</topic><topic>Congenital diseases</topic><topic>Congenital Hypothyroidism - diagnosis</topic><topic>Congenital Hypothyroidism - genetics</topic><topic>Dual Oxidases</topic><topic>Environmental factors</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Variation</topic><topic>Genotype</topic><topic>Homology</topic><topic>Humans</topic><topic>Hydrogen peroxide</topic><topic>Hypothyroidism</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Iodide peroxidase</topic><topic>Iodination</topic><topic>Iodine</topic><topic>Male</topic><topic>Mutation</topic><topic>NAD</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Nonsense mutation</topic><topic>Pedigree</topic><topic>Peroxidase</topic><topic>Phenotype</topic><topic>Phosphates</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Siblings</topic><topic>Splicing</topic><topic>Thyroid</topic><topic>Thyroid Function Tests</topic><topic>Thyroid gland</topic><topic>Thyroid-stimulating hormone</topic><topic>Thyroxine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aycan, Zehra</creatorcontrib><creatorcontrib>Cangul, Hakan</creatorcontrib><creatorcontrib>Muzza, Marina</creatorcontrib><creatorcontrib>Bas, Veysel N</creatorcontrib><creatorcontrib>Fugazzola, Laura</creatorcontrib><creatorcontrib>Chatterjee, V Krishna</creatorcontrib><creatorcontrib>Persani, Luca</creatorcontrib><creatorcontrib>Schoenmakers, Nadia</creatorcontrib><collection>Access via Oxford University Press (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aycan, Zehra</au><au>Cangul, Hakan</au><au>Muzza, Marina</au><au>Bas, Veysel N</au><au>Fugazzola, Laura</au><au>Chatterjee, V Krishna</au><au>Persani, Luca</au><au>Schoenmakers, Nadia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2017-09</date><risdate>2017</risdate><volume>102</volume><issue>9</issue><spage>3085</spage><epage>3090</epage><pages>3085-3090</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Abstract
Context
The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined.
Case Description
We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) <0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G>C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred.
Conclusion
This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.
Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH.</abstract><cop>Washington, DC</cop><pub>Endocrine Society</pub><pmid>28633507</pmid><doi>10.1210/jc.2017-00529</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3085-3090 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5587079 |
source | ProQuest One Community College; MEDLINE; ProQuest Central (Alumni Edition); Journals@Ovid Complete; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection; ProQuest Central |
subjects | Biosynthesis Case Reports Chemical reactions Codon, Nonsense Cohort Studies Congenital diseases Congenital Hypothyroidism - diagnosis Congenital Hypothyroidism - genetics Dual Oxidases Environmental factors Female Genetic Predisposition to Disease Genetic Variation Genotype Homology Humans Hydrogen peroxide Hypothyroidism Infant Infant, Newborn Iodide peroxidase Iodination Iodine Male Mutation NAD NADPH Oxidases - genetics NADPH Oxidases - metabolism Nonsense mutation Pedigree Peroxidase Phenotype Phosphates Retrospective Studies Severity of Illness Index Siblings Splicing Thyroid Thyroid Function Tests Thyroid gland Thyroid-stimulating hormone Thyroxine |
title | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T07%3A24%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Digenic%20DUOX1%20and%20DUOX2%20Mutations%20in%20Cases%20With%20Congenital%20Hypothyroidism&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Aycan,%20Zehra&rft.date=2017-09&rft.volume=102&rft.issue=9&rft.spage=3085&rft.epage=3090&rft.pages=3085-3090&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/jc.2017-00529&rft_dat=%3Cproquest_pubme%3E1970003574%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1970003574&rft_id=info:pmid/28633507&rft_oup_id=10.1210/jc.2017-00529&rfr_iscdi=true |